AIDS Patient Care and STDs · 2020 · 33 citations · 40 references
MedicineCommunity HealthMaternal HealthContraceptionFamily PlanningReproductive HealthAdolescent ContraceptionContraceptive MethodsPre-exposure ProphylaxisPreconception CarePreconception CounselingSexual HealthBeliefs About ContraceptionContraceptive Method ChoiceContraceptive PreferencesContraceptive Use PatternsDecision-making In Contraceptive ChoiceHiv Pre-exposure ProphylaxisSexual Health PlanningSexual Minority Health
Addressing women's low uptake of HIV pre-exposure prophylaxis (PrEP) requires improved understanding of their product preferences. Such preferences should be contextualized according to other aspects of their reproductive health, including their contraception practices. We investigated women's preferences across 10 PrEP modalities currently available or under study and examined associations between PrEP modality preferences and contraception practices. Heterosexually active women recently engaged in care at Connecticut Planned Parenthood centers (n = 563) completed an online survey. Participants were presented with images and descriptions of 10 PrEP modalities and asked to indicate their preference and specify their reasoning in an open-response format. Participants also reported prior and current use of 16 contraception modalities along with relationship, sexual health, and sociodemographic characteristics. The sample included women ages 18–45 (45.3% 25 or younger) who were predominantly non-Hispanic black (35.7%) or white (33.7%). All PrEP modalities presented were preferred by at least some women, with daily pills (24.9%), injections (24.3%), and invisible implants (14.9%) preferred most commonly. Across all modalities, associated reasoning often centered around ease of use and comfort. Coincidence with contraception modality was the third-most common reason underlying women's preferences. Women currently using the analogous contraception modality versus never having used it had higher odds of preferring PrEP daily pills [adjusted odds ratio (AOR) = 2.03], injections (AOR = 8.45), invisible implants (AOR = 11.63), and vaginal rings (AOR = 8.66). Diversification of available PrEP modalities and prioritization of those coinciding with popular contraception practices—especially daily pills, injections, and implants—could optimize PrEP acceptability, encourage PrEP uptake, and ultimately reduce HIV incidence among women.
40
Aaron J. Siegler, Farah Mouhanna, Robertino M. Mera et al. · Annals of Epidemiology · 2018 · 427 citations · Full text
Public Health, Infectious Disease Control, Preventive Medicine +17
Ariane van der Straten, Jonathan Stadler, Elizabeth Montgomery et al. · PLoS ONE · 2014 · 267 citations · Full text
Public Health, Community Health, Infectious Disease Control +17